Background: Atherosclerotic stenosis of large intracranial arteries, especially the middle cerebral artery (MCA), is a common cause of stroke in Chinese patients. We aimed to describe the morphological features of atherosclerotic stenosis in the MCA and to investigate their relationship with cerebral infarcts from a postmortem series. Methods: We studied the morphological features of the MCAs in consecutive postmortem adults aged 45 years or above. The following parameters were evaluated by a single observer blinded to the clinical history: (1) thickness of fibrous cap; (2) extent of lipid area; (3) degree of luminal stenosis; (4) presence of intraplaque hemorrhage, neovasculature, thrombus and calcification. A semiquantitative assessment of macrophage and T lymphocyte infiltration was made by immunohistochemical staining for CD68 and CD45RO. Results: Seventy-six cases were recruited. Atherosclerotic plaques of more than 40% cross-sectional area luminal narrowing stenosis were found in 69 MCAs (45.4%, 69/152). The results demonstrated that the degree of luminal stenosis, the percentage of the plaques containing more than 40% lipid area and the prevalence of intraplaque hemorrhage, neovasculature and thrombus were higher in those plaques associated with infarct, and the mean index of both CD45RO and CD68 was higher among those associated with infarct (p < 0.01). Binary logistic regression showed that stenosis (p = 0.003; odds ratio, OR = 1.050), lipid area (p = 0.048, OR = 1.698) and presence of neovasculature (p = 0.040, OR = 3.471) were independent risk factors of MCA infarcts. Conclusions: Luminal stenosis caused by atherosclerotic plaque, percentage of lipid area and presence of intraplaque neovasculature may play a key role in leading to ischemic stroke.

Keywords:
Atherosclerosis, Middle cerebral artery pathology, Cerebral infarcts
1.
Hollander M, Hak AE, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Witteman JC, Breteler MM: Comparison between measures of atherosclerosis and risk of stroke: the Rotterdam Study. Stroke 2003;34:2367–2372.
2.
Drouet L: Atherothrombosis as a systemic disease. Cerebrovasc Dis 2002;13(suppl 1):1–6.
3.
Libby P, Sukhova G, Lee RT, Liao JK: Molecular biology of atherosclerosis. Int J Cardiol 1997;62(suppl 2):S23–S29.
4.
Fuster V, Badimon L, Badimon JJ, Chesebro JH: The pathogenesis of coronary artery disease and the acute coronary syndromes. Part 1. N Engl J Med 1992;326:242–250.
5.
Virmani R, Kolodgie FD, Burke AP, Farb A, Schwartz SM: Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol 2000;20:1262–1275.
6.
Benavente O, Moher D, Pham B: Carotid endarterectomy for asymptomatic carotid stenosis: a meta-analysis. BMJ 1998;317:1477–1480.
7.
Halliday AW, Thomas DJ, Mansfield AO: The asymptomatic carotid surgery trial (ACST). Int Angiol 1995;14:18–20.
8.
Moore WS, Barnett HJ, Beebe HG, Bernstein EF, Brener BJ, Brott T, Caplan LR, Day A, Goldstone J, Hobson RW 2nd, et al: Guidelines for carotid endarterectomy: a multidisciplinary consensus statement from the ad hoc Committee, American Heart Association. Stroke 1995;26:188–201.
9.
Caplan LR, Gorelick PB, Hier DB: Race, sex and occlusive cerebrovascular disease: a review. Stroke 1986;17:648–655.
10.
Wong KS, Li H, Chan YL, Ahuja A, Lam WW, Wong A, Kay R: Use of transcranial Doppler ultrasound to predict outcome in patients with intracranial large-artery occlusive disease. Stroke 2000;31:2641–2647.
11.
Huang YN, Gao S, Li SW, Huang Y, Li JF, Wong KS, Kay R: Vascular lesions in Chinese patients with transient ischemic attacks. Neurology 1997;48:524–525.
12.
Lin PH, Zhou W, Guerrero MA, McCoy SA, Felkai D, Kougias P, El Sayed HF: Carotid artery stenting with distal protection using the carotid wall stent and filterwire neuroprotection: single-center experience of 380 cases with midterm outcomes. Vascular 2006;14:237–244.
13.
Gupta R, Al-Ali F, Thomas AJ, Horowitz MB, Barrow T, Vora NA, Uchino K, Hammer MD, Wechsler LR, Jovin TG: Safety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulation. Stroke 2006;37:2562–2566.
14.
Jiang WJ, Wang YJ, Du B, Wang SX, Wang GH, Jin M, Dai JP: Stenting of symptomatic M1 stenosis of middle cerebral artery: an initial experience of 40 patients. Stroke 2004;35:1375–1380.
15.
Schenk EA, Bond MG, Aretz TH, Angelo JN, Choi HY, Rynalski T, Gustafson NF, Berson AS, Ricotta JJ, Goodison MW, et al: Multicenter validation study of real-time ultrasonography, arteriography, and pathology: pathologic evaluation of carotid endarterectomy specimens. Stroke 1988;19:289–296.
16.
Thomas AC, Pazios S: The postmortem detection of coronary artery lesions using coronary arteriography. Pathology 1992;24:5–11.
17.
van der Wal AC, Becker AE, van der Loos CM, Das PK: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994;89:36–44.
18.
Burke AP, Kolodgie FD, Zieske A, Fowler DR, Weber DK, Varghese PJ, Farb A, Virmani R: Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study. Arterioscler Thromb Vasc Biol 2004;24:1266–1271.
19.
Jander S, Sitzer M, Schumann R, Schroeter M, Siebler M, Steinmetz H, Stoll G: Inflammation in high-grade carotid stenosis: a possible role for macrophages and T cells in plaque destabilization. Stroke 1998;29:1625–1630.
20.
Piek JJ, van der Wal AC, Meuwissen M, Koch KT, Chamuleau SA, Teeling P, van der Loos CM, Becker AE: Plaque inflammation in restenotic coronary lesions of patients with stable or unstable angina. J Am Coll Cardiol 2000;35:963–967.
21.
Rao DS, Goldin JG, Fishbein MC: Determinants of plaque instability in atherosclerotic vascular disease. Cardiovasc Pathol 2005;14:285–293.
22.
Liu HM, Tu YK, Yip PK, Su CT: Evaluation of intracranial and extracranial carotid steno-occlusive diseases in Taiwan Chinese patients with MR angiography: preliminary experience. Stroke 1996;27:650–653.
23.
Uehara T, Tabuchi M, Mori E: Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese. Eur J Neurol 2005;12:218–222.
24.
Leung SY, Ng TH, Yuen ST, Lauder IJ, Ho FC: Pattern of cerebral atherosclerosis in Hong Kong Chinese: severity in intracranial and extracranial vessels. Stroke 1993;24:779–786.
25.
Fuster V: Lewis A. Conner memorial lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation 1994;90:2126–2146.
26.
European Carotid Surgery Trialists’ Collaborative Group: Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998;351:1379–1387.
27.
Bae HJ, Yoon BW, Kang DW, Koo JS, Lee SH, Kim KB, Lee J, Roh JK: Correlation of coronary and cerebral atherosclerosis: difference between extracranial and intracranial arteries. Cerebrovasc Dis 2006;21:112–119.
28.
Mohr JP, Lazar RM, Marshall RS, Gautier JC, Hier DB: Middle cerebral artery disease; in Barnett HJM, Mohr JP, Stein BM, Yatsu FM (eds): Stroke: Pathophysiology, Diagnosis, and Management, ed 3. Philadelphia, Churchill Livingstone, 1998, pp 427–479.
29.
Wong KS, Gao S, Chan YL, Hansberg T, Lam WW, Droste DW, Kay R, Ringelstein EB: Mechanisms of acute cerebral infarctions in patients with middle cerebral artery stenosis: a diffusion-weighted imaging and microemboli monitoring study. Ann Neurol 2002;52:74–81.
30.
Naritomi H, Sawada T, Kuriyama Y, Kinugawa H, Kaneko T, Takamiya M: Effect of chronic middle cerebral artery stenosis on the local cerebral hemodynamics. Stroke 1985;16:214–219.
31.
Caplan LR, Hennerici M: Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998;55:1475–1482.
32.
Gillard JH, Hardingham CR, Kirkpatrick PJ, Antoun NM, Freer CE, Griffiths PD: Evaluation of carotid endarterectomy with sequential MR perfusion imaging: a preliminary report. AJNR Am J Neuroradiol 1998;19:1747–1752.
33.
Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW: A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1995;92:1355–1374.
34.
Zamir M, Silver MD: Vasculature in the walls of human coronary arteries. Arch Pathol Lab Med 1985;109:659–662.
35.
Zamir M, Silver MD: ‘Hemorrhagic’ and microvascular phenomena within the arterial wall. Can J Cardiol 1992;8:981–984.
36.
Kumamoto M, Nakashima Y, Sueishi K: Intimal neovascularization in human coronary atherosclerosis: its origin and pathophysiological significance. Hum Pathol 1995;26:450–456.
37.
Blanco M, Rodriguez-Yanez M, Sobrino T, Leira R, Castillo J: Platelets, inflammation, and atherothrombotic neurovascular disease: the role of endothelial dysfunction. Cerebrovasc Dis 2005;20(suppl 2):32–39.
38.
Kaperonis EA, Liapis CD, Kakisis JD, Dimitroulis D, Papavassiliou VG: Inflammation and atherosclerosis. Eur J Vasc Endovasc Surg 2006;31:386–393.
39.
Tiong AY, Brieger D: Inflammation and coronary artery disease. Am Heart J 2005;150:11–18.
40.
Falk E, Shah PK, Fuster V: Coronary plaque disruption. Circulation 1995;92:657–671.
41.
Lehtonen-Smeds EM, Mayranpaa M, Lindsberg PJ, Soinne L, Saimanen E, Jarvinen AA, Salonen O, Carpen O, Lassila R, Sarna S, Kaste M, Kovanen PT: Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease: results from the Helsinki Carotid Endarterectomy Study. Cerebrovasc Dis 2005;19:291–301.
42.
Tan TY, Chang KC, Liou CW, Schminke U: Prevalence of carotid artery stenosis in Taiwanese patients with one ischemic stroke. J Clin Ultrasound 2005;33:1–4.
43.
Fatar M, Stroick M, Griebe M, Hennerici M: Matrix metalloproteinases in cerebrovascular diseases. Cerebrovasc Dis 2005;20:141–151.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.